Skip to main content

Tandem Health

Category: AI in Healthcare

An AI-powered clinician co-pilot designed to streamline clinical workflows by automatically transcribing and summarizing patient-provider conversations into structured medical notes. Tandem Health was founded in 2023. The company is led by Lukas Saari. Based in Stockholm, Sweden. Total funding raised: ~$59.5M. Latest round: Series A. Key investors include Kinnevik (lead), Northzone, Amino Collective, Visionaries Club, Angel investors from OpenAI and DeepMind.

Founded
2023
Headquarters
Stockholm, Sweden
Total funding
~$59.5M

Value proposition

Reduces clinician administrative burden and burnout by automating note-taking with generative AI, thereby increasing time available for patient care and improving documentation quality.

Products and solutions

AI Medical Scribe (MDR Class IIa certified), Coding Assistant (MDR Class IIa certified), Automated medical note generation, Referral letters and clinical documentation, ICD-10 and SNOMED code suggestions, Personalised Memories (learns clinician writing style), Tandem Secretary, Integration with 100+ EHR systems, Multi-language support, Philips SpeechMike Ambient wireless audio capture

Unique value

Unlike basic transcription services, Tandem uses advanced generative AI trained on diverse medical datasets to interpret clinical conversations contextually. It is designed to comply with GDPR and other European data protection regulations for medical use.

Target customer

Hospitals, specialty clinics, and general practitioners in the European market.

Industries served

Healthcare

Technology advantage

Proprietary AI models fine-tuned for high accuracy across multiple specialties and languages. Deep integration into existing EHRs for seamless workflow adoption.

How they differentiate

Tandem positions itself as a 'co-pilot' that generates insights, rather than just a 'scribe' that transcribes. It focuses on deep workflow integration and providing actionable recommendations beyond simple documentation.

Main competitors

Abridge Health, Nuance DAX Copilot (Microsoft), Suki.AI, Corti

Key partnerships

5,000+ care organisations across Europe. Accurx (exclusive NHS AI scribe partner, Apr 2025). Humanitas (Italy expansion, Apr 2026). Doctor Care Anywhere (Apr 2026). CGI (Finland, Jan 2026). Cambio (strategic partnership, Aug 2025). Juvoly (acquired, Jan 2026). NHS multi-trust agreement (10,000 clinicians, Mar 2026). Philips SpeechMike Ambient (Jun 2026). E-Medicus (Switzerland, Aug 2025). Recoletas (Spain, Jul 2025). Eterno (Germany, May 2025). Integrates with 100+ EHR systems.

Notable customers

Over 5,000 care organisations across Europe including Capio, Ramsay Santé, Mindler, Aleris, Recoletas, and Rothschild Hospital. NHS multi-trust agreement covering 10,000 clinicians. Accurx partnership reaching 200,000+ NHS staff.

Major milestones

Founded in 2023., Raised a $9.5M seed round in June 2024., Secured a $50M Series A funding round in June 2025., Expanded to over 5,000 healthcare organizations across 10+ European markets., Acquired Juvoly (Netherlands' leading AI scribe) in Jan 2026., Coding Assistant achieved MDR Class IIa certification (Feb 2026)., Four-year NHS multi-trust agreement for 10,000 clinicians (Mar 2026)., Entered Italy via Humanitas partnership (Apr 2026)., Doctor Care Anywhere partnership (Apr 2026)., AI Scribe became first in Europe to reach EU MDR Class IIa (May 2026)., Philips SpeechMike Ambient partnership (Jun 2026).

Growth metrics

Expanded team to approximately 150 employees. Trusted by 5,000+ care organisations across 10+ European markets. Integrates with 100+ EHR systems. AI Scribe and Coding Assistant both MDR Class IIa certified.

Market positioning

A solution targeting a wide range of provider organizations, from small general practices to large hospitals, focused on improving operational efficiency.

Geographic focus

Europe (active in 10+ markets: Nordics, UK, Germany, France, Spain, Italy, Netherlands, Switzerland, Finland, and more)

Patents and IP

Information not publicly available.

About Lukas Saari

Lukas Saari is the CEO and Co-Founder of Tandem Health. He co-founded the company in August 2023. Prior to Tandem Health, he was an Engagement Manager at McKinsey & Company, where he focused on healthcare analytics. He also has experience as a Machine Learning Engineer at Spotify and a Data Scientist at King.

Official website: